New Principal Investigators

Dr. Jayne Danska
Associate Professor and Senior Scientist, Hospital for Sick Children
Research interests include genetics and immunology of insulin dependent diabetes mellitus, including the elucidation of 'pre-clinical phenotypes'using NOD mouse model; and the development of lymphoma through the mis-joining of double strand breaks.

Dr. William Foulkes
Assistant Professor, Departments of Medicine, Human Genetics and Oncology,McGill University
Research interests include DNA and tissue profiling in hereditary breast cancer: the influence of BRCA1 and BRCA2 mutations on phenotype and outcome.

Dr. Geoff Hicks
Assistant Professor, University of Manitoba
Research interests include (1) molecular mechanisms of TLS (acute myeloid leukemia)in the maintenance of genomic stability (2) mammalian functional genomics: 20,000 - 40,000 ES cell mutation library.

New Network Scholars


Dr. Susan Andrew
Assistant Professor, University of Alberta
Research interests: role of lack of DNA mismatch repair and resulting
genomic instability in the hereditary cancer syndrome HNPCC, as well as
possible mechanisms of trinucleotide repeat expansion that underlie many neurological disorders

Dr. Moira Glerum
Assistant Professor, University of Alberta
Research interests: mitochrondrial biogenesis and the defects in this process that lead to inherited mitochrondrial disorders in humans.

Dr. Celia Greenwood
Assistant Professor, McGill University Health Centre
Research interests: developing statistical methodology for the analysis of human genetic disease - to improve methods for linkage and linkage disequilibrium analysis.

Dr. Christopher Pearson
Assistant Professor, Hospital for Sick Children
Research interests: Understanding mechanisms responsible for disease-associated genomic instability, including neurological disease-associated trinucleotide instability, aberrant epigentic maintenance, genome instabilities caused by repair or replication deficiencies, cancer and age-associated telomere instability.

Dr. Bruce Rannala
Assistant Professor, University of Alberta
Research interests include bioinformatics and mathematical genetics aspects of disequilibrium mapping of complex human diseases.

New Stem Cell Genomics and Therapeutics Network funded by federal NCE program – Network headed by CGDN senior scientist, Dr. Ronald Worton.
Policy paper on Stem Cell Research
Dr. Alan Bernstein, President of the Canadian Institutes of Health Research, released a discussion paper, Human Stem Cell Research: Opportunities for Health and Ethical Perspectives on proposed guidelines for funding of human embryonic stem cell research in Canada.

International Biotechnology Journalists Tour Canada - CGDN participates in the program.
As part of a program arranged by the Ottawa Life Sciences Council, in conjunction with the Canadian Genetic Diseases Network and the Department of Foreign Affairs and International Trade, Taiwanese journalists from The Economic Daily and the Commonwealth Magazine met with biotechnology companies and CGDN management and scientists in Vancouver and Montreal. They were joined in eastern Canada by journalists from Sweden, Finland, and Denmark. Vancouver, Mar.23, 2001

Michael Smith Foundation for Health launched by the Government of B.C.
This new B.C. fund will support Health Research - $110 million funding to be spent with interest over the next five years.
University of British Columbia, Vice President of Research, Mar.26, 2001

Benefits of biotech outweigh ethical concerns, says Bernstein (CIHR chief)
Alan Bernstein, the president of CIHR, says he’s excited about the fact that Canada has finally understood the importance of health research. Dr. Bernstein predicts current advances in biotechnology will have tremendous benefits to human health. In terms of the ethical concerns over some biotech research, Dr. Bernstein says critics need to look at the larger picture.

Balancing Act: Science & Society
Medicine's basic mode will change, shifting from treatment to the prevention of illness, says Alan Bernstein (CIHR chief)
Globe & Mail, Feb.14, 2001

Charities ‘Thank God’ For Drug Firms’ Money
Support groups not ashamed of aid from big companies, and indeed say they would be in trouble without it.
Globe and Mail, Jan.4, 2001